Stockscreener 앱 받기
42.65
2.74%
-1.20
시장 영업 전:
42.23
-0.42
-0.98%
전일 마감가:
$43.85
열려 있는:
$43.4
하루 거래량:
4.10M
Relative Volume:
1.57
시가총액:
$8.80B
수익:
$2.10B
순이익/손실:
$402.17M
주가수익비율:
22.03
EPS:
1.9357
순현금흐름:
$403.87M
1주 성능:
+0.76%
1개월 성능:
+2.75%
6개월 성능:
-16.47%
1년 성능:
-11.16%
1일 변동 폭
$42.60
$43.46
1주일 범위
$40.87
$44.41
52주 변동 폭
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
42.65 | 8.47B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
605.00 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.44 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
586.64 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
312.72 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
149.49 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2026-03-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-22 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen Sees Unusually High Options Volume (NYSE:QGEN) - MarketBeat
Goldman Sachs lifts Qiagen voting rights to 2.63% via instruments - Bitget
Qiagen NV (QGEN) Shares Surge 3.7% -- What GF Score of 76 Tells Investors - GuruFocus
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel - Business Wire
QGEN Maintained by Citigroup -- Price Target Raised to $45.00 - GuruFocus
Understanding Qiagen (QGEN) Reliance on International Revenue - Yahoo Finance
Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential With An 8.24% Upside - DirectorsTalk Interviews
Qiagen N.V. : Deutsche Bank remains its Buy rating - marketscreener.com
63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company - MarketBeat
Qiagen Q2 Earnings Call Highlights - TradingView
QIAGEN Beats Q2 2026 Guidance, Reaffirms Full-Year Outlook Amid Mixed Demand - The Globe and Mail
William Blair Maintains Qiagen NV(QGEN.US) With Hold Rating - 富途牛牛
How Investors Are Reacting To Qiagen (QGEN) Capital Structure Overhaul And US$200 Million Repayment Plan - Sahm
Qiagen N.V. Stock 12‑Month Price Target Raised to $44.52, Implies 7% Upside - TradingView
QGEN Maintained by Barclays -- Price Target Raised to $40 - GuruFocus
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen NV (QIA.SG) stock price, news, quote and history - Yahoo Finance UK
QGEN Maintained by JP Morgan -- Price Target Raised to $50 - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $50.00 - MarketBeat
A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09 - Moomoo
Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Qiagen N.V. (QGEN) Stock Forecasts - Yahoo Finance
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen N.V. (NYSE: QGEN) Q2 2026 profit, $496.7M synthetic buyback and cash flows - Stock Titan
QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets - Stock Titan
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Analysts - MarketBeat
Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN - MarketBeat
Bank of America Corp DE Sells 418,992 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen (QGEN) Stock Faces An Execution Puzzle After Margin Rebound - Sahm
Qiagen NV (QGEN) (Q2 2026) Earnings Call Highlights: Beats Guida - GuruFocus
Qiagen (NYSE:QGEN) Updates Q3 2026 Earnings Guidance - MarketBeat
QIAGEN Q2 2026 slides: flat growth masks strong pillar performance - Investing.com
Qiagen: Q2 ahead of expectations; like peers, there's no change to guidance - marketscreener.com
Qiagen NV (0RLT) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Qiagen N.V. 2026 Q2ResultsEarnings Call Presentation (NYSE:QGEN) 2026-08-06 - Seeking Alpha
QIAGEN NV QIAGEN ORD SHS (0RLT.IL) Q2 FY2026 earnings call transcript - Yahoo Finance
QIAGEN NV : Buy rating from Jefferies - marketscreener.com
QIAGEN NV : Deutsche Bank maintains a Buy rating - marketscreener.com
Qiagen N.V. Q2 2026 Earnings Call Summary - Yahoo Finance
QIAGEN N.V. (NYSE: QGEN) sets $0.35 dividend and $200M buyback cap - Stock Titan
QIAGEN N.V. reports results for the quarter ended June 30Earnings Summary - TradingView
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Qiagen (QGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Qiagen: Q2 Earnings Snapshot - marketscreener.com
Qiagen Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Qiagen reports flat Q2 sales, reaffirms 2026 outlook - Investing.com
Qiagen reports flat Q2 sales, reaffirms 2026 outlook By Investing.com - Investing.com Nigeria
Norges Bank Discloses 3.10% Stake in Qiagen - The Globe and Mail
Earnings Flash (QGEN) QIAGEN N.V. Reports Q2 Revenue $535.0M, vs. FactSet Est of $527.5M - marketscreener.com
Earnings Flash (QGEN) QIAGEN N.V. Posts Q2 Adjusted EPS $0.62 per Share, vs. FactSet Est of $0.60 - marketscreener.com
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.35%
자본화:
|
볼륨(24시간):